• Fauci: COVID-19 vaccines the ‘bright light of this extraordinary challenge' By Healio   -   May 17, 2021

    FAUCI: COVID-19 VACCINES THE ‘BRIGHT LIGHT OF THIS EXTRAORDINARY CHALLENGE'

    COVID-19 took center stage at the opening ceremony of the American Thoracic Society International Conference, with a virtual keynote...

    Vaccination, Allergies
  • Removing race correction in lung function tests shows more severe disease in Black patients By Healio   -   May 17, 2021

    REMOVING RACE CORRECTION IN LUNG FUNCTION TESTS SHOWS MORE SEVERE DISEASE IN BLACK PATIENTS

    In a new study, removing “race correction” from the interpretation of pulmonary function test results signaled more prevalent and severe...

    Allergies
  • No reduction in late ischemic events with rapid troponin protocol for suspected ACS By Healio   -   May 17, 2021

    NO REDUCTION IN LATE ISCHEMIC EVENTS WITH RAPID TROPONIN PROTOCOL FOR SUSPECTED ACS

    Use of a rapid high-sensitivity cardiac troponin T assay protocol for suspected ACS resulted in earlier discharge and less functional...

  • REHAB-HF: Rehabilitation program improves physical function in older adults with HF By Healio   -   May 17, 2021

    REHAB-HF: REHABILITATION PROGRAM IMPROVES PHYSICAL FUNCTION IN OLDER ADULTS WITH HF

    Older adults hospitalized for acute HF who participated in a progressive 12-week rehabilitation program had better outcomes compared...

    Hospital
  • Cardioprotective therapies fail to prevent LVEF decline in early breast cancer treatment By Healio   -   May 17, 2021

    CARDIOPROTECTIVE THERAPIES FAIL TO PREVENT LVEF DECLINE IN EARLY BREAST CANCER TREATMENT

    Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly...

    Breasts, Cancer, Breast
  • PARAGON-HF: Sacubitril/valsartan reduces triglyceride levels in HFpEF By Healio   -   May 17, 2021

    PARAGON-HF: SACUBITRIL/VALSARTAN REDUCES TRIGLYCERIDE LEVELS IN HFPEF

    Sacubitril/valsartan drastically reduced triglycerides compared with valsartan in patients with HF with preserved ejection fraction,...

  • FFR strategy may not top angiography strategy in STEMI, complete revascularization By Healio   -   May 17, 2021

    FFR STRATEGY MAY NOT TOP ANGIOGRAPHY STRATEGY IN STEMI, COMPLETE REVASCULARIZATION

    Among patients with STEMI who underwent complete revascularization, a fractional flow reserve-guided strategy did not improve outcomes...

  • Pixee Medical receives 510 clearance for knee arthroplasty augmented reality glasses By Healio   -   May 17, 2021

    PIXEE MEDICAL RECEIVES 510 CLEARANCE FOR KNEE ARTHROPLASTY AUGMENTED REALITY GLASSES

    Pixee Medical received FDA 510 clearance for its Knee+ augmented reality, surgical navigation device for knee arthroplasty, according...

    Plan, Knees
  • Patients hospitalized with flu, CAP frequently have bacterial coinfection By Healio   -   May 17, 2021

    PATIENTS HOSPITALIZED WITH FLU, CAP FREQUENTLY HAVE BACTERIAL COINFECTION

    Around 10% of patients hospitalized for influenza and community-acquired pneumonia also had a community-onset bacterial coinfection,...

    Flu, Hospital
  • DARE-19: No significant decrease in major events; dapagliflozin well tolerated in COVID-19 By Healio   -   May 17, 2021

    DARE-19: NO SIGNIFICANT DECREASE IN MAJOR EVENTS; DAPAGLIFLOZIN WELL TOLERATED IN COVID-19

    The SGLT2 inhibitor dapagliflozin did not significantly reduce risk for organ failure or death or improve recovery among adults hospitalized...

    Hospital
  • Evinacumab shows benefit in certain patients with severe hypertriglyceridemia By Healio   -   May 17, 2021

    EVINACUMAB SHOWS BENEFIT IN CERTAIN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA

    In a phase 2 study, evinacumab reduced triglyceride levels in patients with severe hypertriglyceridemia but not familial chylomicronemia...

    Hospital
  • Prediabetes confers elevated risk for major adverse CV events By Healio   -   May 17, 2021

    PREDIABETES CONFERS ELEVATED RISK FOR MAJOR ADVERSE CV EVENTS

    Adults with prediabetes were more likely to have an MI and other CV events compared with those who had normal blood glucose levels,...

    Diabetes
  • Half of patients with CVD report they received influenza vaccine in past year By Healio   -   May 17, 2021

    HALF OF PATIENTS WITH CVD REPORT THEY RECEIVED INFLUENZA VACCINE IN PAST YEAR

    Among patients with CVD living in the U.S., only half reported they received an influenza vaccine in the past year, according to data...

    Vaccination
  • Left atrial appendage occlusion during cardiac surgery reduces stroke risk By Healio   -   May 17, 2021

    LEFT ATRIAL APPENDAGE OCCLUSION DURING CARDIAC SURGERY REDUCES STROKE RISK

    In the LAAOS III trial, concomitant left atrial appendage occlusion during cardiac surgery for another indication reduced the risk...

    Stroke
  • Apixaban post-TAVR not superior to standard care By Healio   -   May 17, 2021

    APIXABAN POST-TAVR NOT SUPERIOR TO STANDARD CARE

    Apixaban was not superior to standard of care antithrombotic treatment for preventing thrombotic or bleeding events after successful...

  • Marked health status improvement with mavacamten in obstructive hypertrophic cardiomyopathy By Healio   -   May 17, 2021

    MARKED HEALTH STATUS IMPROVEMENT WITH MAVACAMTEN IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

    The cardiac myosin inhibitor mavacamten substantially improved health status in patients with symptomatic obstructive hypertrophic...

  • TWILIGHT: Benefit of ticagrelor monotherapy after PCI similar in men, women By Healio   -   May 17, 2021

    TWILIGHT: BENEFIT OF TICAGRELOR MONOTHERAPY AFTER PCI SIMILAR IN MEN, WOMEN

    Among patients who underwent PCI with a drug-eluting stent, switching from dual antiplatelet therapy to ticagrelor monotherapy at 3...

    Drugs
  • NODE-301: Etripamil may benefit patients with paroxysmal supraventricular tachycardia By Healio   -   May 17, 2021

    NODE-301: ETRIPAMIL MAY BENEFIT PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

    Etripamil nasal spray was associated with improving symptoms and reducing ED visits to terminate nodal-dependent paroxysmal supraventricular...

  • Sustained reduction in lung function decline over longer-term with nintedanib in SSc-ILD By Healio   -   May 17, 2021

    SUSTAINED REDUCTION IN LUNG FUNCTION DECLINE OVER LONGER-TERM WITH NINTEDANIB IN SSC-ILD

    In the SENSCIS-ON trial, two-thirds of patients with systemic sclerosis-associated interstitial lung disease who continued nintedanib...

  • Gefapixant reduces chronic cough frequency in large pooled analysis By Healio   -   May 17, 2021

    GEFAPIXANT REDUCES CHRONIC COUGH FREQUENCY IN LARGE POOLED ANALYSIS

    Gefapixant 45 mg twice daily resulted in clinically important reductions in cough frequency compared with placebo in patients with...

    Drugs